ArticleJournal of cellular and molecular medicine2025

Cinobufagin Enhances the Sensitivity of Cisplatin-Resistant Lung Cancer Cells to Chemotherapy by Inhibiting the PI3K/AKT and MAPK/ERK Pathways.

Guangxin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.